We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mobile-Compatible AI-Powered System to Revolutionize Malaria Diagnosis

By LabMedica International staff writers
Posted on 04 Sep 2025

Malaria remains a major health burden in Malaysia, with Plasmodium knowlesi now the leading cause of human cases. More...

Its rapid replication cycle and similarities to other malaria species make timely and accurate diagnosis particularly difficult. In rural clinics, trained parasitologists are scarce, and misidentification is common. To address these gaps, researchers have developed a locally tailored artificial intelligence (AI) system that enhances the accuracy and speed of malaria diagnosis.

The new system, called MalariaCare+, was created by a team at Universiti Malaya (UM, Kuala Lumpur, Malaysia) and uses a graph-enhanced YOLO deep learning model to detect infected red blood cells, even on overlapping or low-quality slides. MalariaCare+ is being tested in collaboration with Universiti Malaysia Sarawak (UNIMAS, Sarawak, Malaysia) and has been integrated into an app tested with blood samples.

Designed for local realities, it is mobile-compatible and acts as a diagnostic assistant rather than a replacement for medical professionals. Early results show the AI providing healthcare workers with reliable “second set of expert eyes,” improving diagnostic accuracy in real-world rural conditions. The system’s design, shaped by input from doctors, technicians, and field researchers, ensures responsiveness to the on-the-ground challenges of malaria detection in Malaysia.

Next steps include adding a stage-specific classifier to identify Plasmodium knowlesi life stages, enabling faster treatment decisions. Planned updates will bring real-time analysis, visual explanations of AI findings, and secure patient history tracking that works even in low-connectivity areas. In addition to diagnosis, MalariaCare+ will be integrated into public health training at UM and UNIMAS, equipping future healthcare workers with both biological and technological expertise.

“This isn’t AI for the sake of it. This is applied intelligence; built with and for the people who deal with malaria on the ground,” said Associate Professor Dr. Khairunnisa Hasikin, project lead at Universiti Malaya. “We trained the AI to see what even the sharpest eyes might miss. It’s not about replacing doctors and clinicians. It’s about giving them a second set of expert eyes when they need it most.”

Related Links:
Universiti Malaya
UNIMAS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Urinalysis Solution
UN-9000
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.